UCSF researchers identify a molecular link between thymic tumors and autoimmunity
UCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
University of California San Francisco
Give to UCSFUCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
Mission Bay Capital, LLC, has added a new limited partner to its first venture fund, bolstering the fund’s ability to invest in promising bioscience companies emerging from the University of California.
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.
People with symptoms of depression in middle age have a significantly greater risk in old age of being physically disabled or unable to carry out tasks of daily living, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
UCSF has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.
A UCSF team, led by bioethicist Bernard Lo, MD, recommends that the National Institutes of Health ethics guidelines for embryonic stem cell research be modified to better protect the rights of individuals donating egg or sperm to patients undergoing in vitro fertilization.
UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.
UCSF is sponsoring a one-day symposium for the Bay Area research community to bring awareness to the problem of how certain foods can cause an addictive-like state in the brain and are a hidden cause behind the nation's obesity epidemic.
Senator Arlen Specter (D-PA) will join UCSF Chancellor Susan Desmond- Hellmann for a town hall meeting with UCSF faculty, staff, and students on February 16, 2010.
Among soldiers who served in Iraq, the act of taking a life in combat was a significant predictor of post-traumatic stress disorder, alcohol abuse, hostility and anger, and relationship problems, according to a study led by a psychologist at the San Francisco VA Medical Center.
Scientists have determined that a new instrument known as PIB-PET is effective in detecting deposits of amyloid-beta protein plaques in the brains of living people, and that these deposits are predictive of who will develop Alzheimer’s disease.
Between 2002 and 2008, fewer than 10 percent of U.S. veterans of the wars in Iraq and Afghanistan who were newly diagnosed with post-traumatic stress disorder received the recommended course of care for their condition at VA health facilities, according to a study by researchers at the San Francisco VA Medical Center and UCSF.
The UCSF School of Dentistry will offer free cleanings, dental sealants and fluoride treatments as part of the citywide “Give Kids a Smile Day.” Each child will receive a free toothbrush, toothpaste and floss. UCSF faculty, volunteer dentists and dental students will provide free dental screenings to satisfy the Kindergarten/1st Grade Oral Health Assessment Bill requirements. Services will be offered on a first-come, first-served basis. Members of the media are invited to attend from 9 a.m. to 11 a.m.
A landmark textbook focusing on lesbian health, based on extensive research and the clinical experience of its 46 chapter authors, is now available.
Donna Ferriero, MD, UCSF chief of pediatric neurology, has been appointed to the National Neurological Disorders and Stroke Advisory Council. The 18 member council, composed of physicians, scientists and representatives of the public, serves as the principal advisory body to the National Institute of Neurological Disorders and Stroke (NINDS) regarding the Institute’s research program planning and priorities.
UCSF researchers have identified an elusive molecular regulator that controls the ability of human sperm to reach and fertilize the egg, a finding that has implications on both treating male infertility and preventing pregnancy.
National experts in health care research and policy will convene on Friday, January 29, to discuss how to take some of the guesswork out of doctors’ treatment decisions, with the goal of improving health care.
A UCSF analysis of published studies on the relationship between Alzheimer’s disease and smoking indicates that smoking cigarettes is a significant risk factor for the disease.
A laptop containing files with patient information was stolen from a UCSF School of Medicine employee on or about November 30, 2009. UCSF is in the process of alerting approximately 4,310 patients that their protected health information is vulnerable to access as a result of the incident.
Some of the leading scientists in bioengineering, nanotechnology and pharmaco-genomics will gather on Tuesday, January 26, 2010 to discuss how to harness the tools of these emerging fields to develop new diagnostics and treatments for complex diseases.
A federal pediatric advisory committee has voted unanimously to include a screening test for Severe Combined Immune Deficiency, or SCID, in the core panel of newborn screening performed nationwide. The Federal Advisory Committee on Heritable Disorders in Newborns and Children formally recommended the screen January 21.
UCSF scientists have received a $10 million grant from the National Institutes of Health to embark on a major neuroimaging study of a degenerative brain disease that is at least as common as Alzheimer’s disease in people under age 60.
Scientists have identified a gene family that plays a key role in one of the earliest stages of development in which an embryo distinguishes its left side from the right and determines how organs should be positioned within the body. The finding in mice likely will lead to a better understanding of how certain birth defects occur in humans.
UCSF is set to construct a major neuroscience building on its Mission Bay campus. The building will bring under one roof several of the world’s leading clinical and basic research programs seeking cures for intractable neurological disorders.
UCSF has appointed John Plotts, a 30-year financial veteran, to oversee the fiscal and operational management of the life sciences university.
Non-smokers with both long-term exposure to second-hand cigarette smoke and narrowing of the artery that brings blood to the brain had three times the risk of developing dementia than people without either of those risk factors, according to a study led by a researcher at the San Francisco VA Medical Center.